Why is Aurobindo Pharma falling/rising?

As of 03-Nov, Aurobindo Pharma Ltd. is experiencing a price increase, currently at 1,155.25, reflecting a rise of 16.6 points or 1.46%. The stock has been gaining momentum over the last two days, with a total return of 4.78% during this period. It has also reached an intraday high of Rs 1163.85, indicating positive trading activity. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which suggests a bullish trend. Additionally, there has been a significant increase in delivery volume, rising by 131.9% compared to the 5-day average, indicating heightened investor interest. Despite a year-to-date decline of 13.48%, the company's low debt-to-equity ratio and attractive valuation with a price-to-book value of 2.1 contribute positively to its recent performance. In the broader market context, Aurobindo Pharma's short-term performance has outpaced the benchmark Sensex, which has declined by 0.94% over the past week while Aurobindo Pharma has gained 5.52%. This relative strength may reflect the stock's appeal among institutional investors, who hold 41.81% of the shares and are typically more adept at analyzing company fundamentals. However, it is important to note that the stock has underperformed over the past year, with a return of -17.19%, and its profits have decreased by 6.1%. This mixed performance suggests that while current trends are positive, there are underlying challenges that could affect future price movements.